Press release
Acute Bacterial Skin and Skin Structure Infections Market to see upward surge in Future Scope
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are the type of skin and soft tissue infections that affects the epidermis, dermis, and subcutaneous tissues. The US FDA defines ABSSSI as lesions with cellulitis/erysipelas, wound infections, and major cutaneous abscesses occurring in a minimum surface area of 75 cm2. Pathogens such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa are the major causes of ABSSSI.Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/1531
The major market driver for growth of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market is increasing research and development activities by pharmaceutical and biopharmaceutical companies to develop new products and novel treatment. For instance, in 2017, Cempra announced promising data from the phase 3 trial of Fusidic acid for the treatment of ABSSSI. In same year, Melinta Therapeutics received US FDA for its product Baxdela, a delafloxacin based ABSSSI medicine, available in both intravenous and oral formulations.
Moreover, in 2018, Fresenius Kabi received US FDA approval for new drug application of daptomycin, a lipopeptide class of antibacterial drug, in injectable form for complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pyogenes, Streptococcus agalactlae etc.
Increasing number of ambulatory patients seeking treatment for skin and skin structure infections will further propel growth of the ABSSSI market. For instance, according to article published in 2015 of PLoS One journal, skin and skin structure infections related hospital admissions were 1.6% in 2005, increased to 2.0% in 2011.
Moreover, according to Decision Resource Group, in 2014, 11% of 2.7 million hospital admissions for ABSSSI were pediatric patients. The increasing pediatric patient pool is targeted by the manufacturers to enhance its product portfolio with pediatric specific products. For instance, in 2016, Allergan plc received US FDA approval for its supplemental New Drug Application (sNDA) for Teflaro, for ABSSSI indication in pediatric.
๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐จ๐๐๐๐ซ!!! ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ๐๐ ๐ซ๐๐ญ๐!!!
๐ ๐ฅ๐๐ญ ๐๐ง๐ฌ๐ญ๐๐ง๐ญ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ ๐๐$ ๐๐๐๐
๐๐ฎ๐ฒ ๐๐ก๐ข๐ฌ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.coherentMarketinsights.com/promo/buynow/1531
Major Market Competitors: Paratek Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Allergan plc, Merck & Co., Inc., Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Ltd.), Fresenius SE & Co. KGaA, Sandoz Inc. (a subsidiary of Novartis), Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd., and Teva Pharmaceutical Industries Ltd.
๐ ๐ซ๐๐ช๐ฎ๐๐ง๐ญ๐ฅ๐ฒ ๐๐ฌ๐ค๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ?
๐๐ก๐๐ญ ๐ฐ๐ข๐ฅ๐ฅ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐๐ ๐ข๐ง ๐๐๐๐?
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ฎ๐ซ๐จ๐ฉ๐๐๐ง ๐ฆ๐๐ซ๐ค๐๐ญ?
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐๐ฌ ๐ญ๐จ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก?
๐๐ก๐จ ๐๐ซ๐ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ?
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐๐ง๐ ๐ญ๐ก๐ซ๐๐๐ญ๐ฌ ๐๐๐๐๐ ๐๐ฒ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ?
๐๐ก๐๐ญ ๐ฐ๐ข๐ฅ๐ฅ ๐๐ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ ๐ข๐ง ๐๐๐๐?
๐๐ก๐ข๐๐ก ๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐ซ๐ ๐ฎ๐ฌ๐๐ ๐๐ฒ ๐ญ๐จ๐ฉ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ค๐ค ๐๐๐ซ๐ค๐๐ญ?
Download PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1531
Contact us:
Mr. Shah
Senior Client Partner โ Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com
๐๐ฏ๐ผ๐๐ ๐๐ผ๐ต๐ฒ๐ฟ๐ฒ๐ป๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ป๐๐ถ๐ด๐ต๐๐:-
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Bacterial Skin and Skin Structure Infections Market to see upward surge in Future Scope here
News-ID: 2344539 • Views: โฆ
More Releases from Coherent Market Insights
Meal Replacement Market Market to Hit $22.01 Bn by 2032 with a CAGR of 5.8% |Abb โฆ
The Meal Replacement Market is estimated to be valued at USD 14.82 Bn in 2025 and is expected to reach USD 22.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Meal Replacement Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growthโฆ
Deep Cycle Battery Market, Market Outlook : Projected to Exceed USD 4.73 Billion โฆ
The deep cycle battery market is estimated to be valued at USD 2.77 billion in 2025 and is expected to reach USD 4.73 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Deep Cycle Battery Market, Market from 2025 to 2032. This in-depth analysis covers industry size, market share, businessโฆ
Consumer Electronics Packaging Market Market Projected to Witness Huge Growth by โฆ
The consumer electronics packaging market is estimated to be valued at USD 26.57 Bn in 2025 and is expected to reach USD 81.72 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Consumer Electronics Packaging Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,โฆ
Ceramic Armor Market Market Set to Witness Significant Growth by 2025-2032 |Koni โฆ
The global ceramic armor market is estimated to be valued at USD 2.75 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
The latest report from Coherent Market Insights examines the growth prospects of the Ceramic Armor Market Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,โฆ
More Releases for ABSSSI
Revolutionizing Care: Breakthroughs Propel the ABSSSI Treatment Market into a Ne โฆ
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) represent a significant clinical and economic burden worldwide, affecting patients across outpatient clinics, hospitals, and long-term care facilities. From simple cellulitis to complex wound infections, these conditions require prompt, effective therapy to prevent serious complications and reduce healthcare costs. Today, the ABSSSI treatment market is undergoing a renaissance, driven by novel antibiotic classes, innovative delivery systems, and a heightened focus on antimicrobialโฆ
ABSSSI Therapeutics Market Size in the 7MM is anticipated to increase by 2034 an โฆ
DelveInsight's "Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Acute Bacterial Skin and Skin Structure Infections, historical and forecasted epidemiology as well as the Acute Bacterial Skin and Skin Structure Infections market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock key insights into the ABSSSI Market! Downloadโฆ
Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Treatment Market Size โฆ
Acute Bacterial Skin and Skin Structure Infections Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Acute Bacterial Skin and Skin Structure Infections Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology andโฆ
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market 2022-2028 | P โฆ
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegantโฆ
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market โ Detailed โฆ
Acute Bacterial Skin and Skin Structure Infections Market Report 2021 added recently by Coherent Market Insights, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the Acute Bacterial Skin and Skin Structure Infections depending on the industry's financial and non-financial impact. The complete range of informationโฆ
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Rapidly Devel โฆ
The major market driver for growth of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market is increasing research and development activities by pharmaceutical and biopharmaceutical companies to develop new products and novel treatment. For instance, in 2017, Cempra announced promising data from the phase 3 trial of Fusidic acid for the treatment of ABSSSI. In same year, Melinta Therapeutics received US FDA for its product Baxdela, a delafloxacin basedโฆ
